Laddar...
Stem-cell transplantation in multiple myeloma: how far have we come?
High-dose therapy (HDT) and autologous stem-cell transplantation (ASCT) has historically been an essential part of multiple myeloma (MM) management since early studies demonstrated its efficacy in relapsed disease, and subsequent phase III trials demonstrated better responses and improved survival w...
Sparad:
| I publikationen: | Ther Adv Hematol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859676/ https://ncbi.nlm.nih.gov/pubmed/31798820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719888111 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|